Back to Search Start Over

Screening for Speech and Language Delay and Disorders in Children: US Preventive Services Task Force Recommendation Statement.

Authors :
Barry, Michael J.
Nicholson, Wanda K.
Silverstein, Michael
Chelmow, David
Coker, Tumaini Rucker
Davis, Esa M.
Donahue, Katrina E.
Jaén, Carlos Roberto
Li, Li
Mangione, Carol M.
Ogedegbe, Gbenga
Rao, Goutham
Ruiz, John M.
Stevermer, James
Tsevat, Joel
Underwood, Sandra Millon
Wong, John B.
Source :
JAMA: Journal of the American Medical Association; 1/23/2024, Vol. 331 Issue 4, p329-334, 6p
Publication Year :
2024

Abstract

Importance: Speech and language delays and disorders can pose significant problems for children and their families. Evidence suggests that school-aged children with speech or language delays may be at increased risk of learning and literacy disabilities, including difficulties with reading and writing. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of screening for speech and language delay and disorders in children 5 years or younger. Population: Asymptomatic children 5 years or younger whose parents or clinicians do not have specific concerns about their speech, language, hearing, or development. Evidence Assessment: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children who do not present with signs or symptoms or parent/caregiver concerns. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children 5 years or younger without signs or symptoms. (I statement) This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children 5 years or younger without signs or symptoms (I statement). [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00987484
Volume :
331
Issue :
4
Database :
Complementary Index
Journal :
JAMA: Journal of the American Medical Association
Publication Type :
Academic Journal
Accession number :
175036035
Full Text :
https://doi.org/10.1001/jama.2023.26952